They noted a significantly improved glucagon CRR to hypoglycemia in the AICAR treated diabetic rats as compared to saline treated controls indicating that AMPK manipulation could be a useful pharmaceutical tool to treat IAH (Fan et al., 2009). This evidence concerns the gene GCG and Hypoglycemia.